Stella Xu - Net Worth and Insider Trading
Stella Xu Net Worth
The estimated net worth of Stella Xu is at least $27 Million dollars as of 2024-12-29. Stella Xu is the Director of Design Therapeutics Inc and owns about 4,139,950 shares of Design Therapeutics Inc (DSGN) stock worth over $26 Million. Stella Xu is also the Director of NextCure Inc and owns about 1,103,570 shares of NextCure Inc (NXTC) stock worth over $904,927. Details can be seen in Stella Xu's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stella Xu has not made any transactions after 2022-03-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stella Xu
Stella Xu Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stella Xu owns 3 companies in total, including Tempest Therapeutics Inc (TPST) , NextCure Inc (NXTC) , and Design Therapeutics Inc (DSGN) .
Click here to see the complete history of Stella Xu’s form 4 insider trades.
Insider Ownership Summary of Stella Xu
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TPST | Tempest Therapeutics Inc | 2021-06-25 | director |
| NXTC | NextCure Inc | 2019-05-13 | director & 10 percent owner |
| DSGN | Design Therapeutics Inc | 2022-03-22 | director & 10 percent owner |
Stella Xu Latest Holdings Summary
Stella Xu currently owns a total of 2 stocks. Among these stocks, Stella Xu owns 4,139,950 shares of Design Therapeutics Inc (DSGN) as of March 22, 2022, with a value of $26 Million and a weighting of 96.62%. Stella Xu also owns 1,103,570 shares of NextCure Inc (NXTC) as of May 13, 2019, with a value of $904,927 and a weighting of 3.38%.
Latest Holdings of Stella Xu
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DSGN | Design Therapeutics Inc | 2022-03-22 | 4,139,950 | 6.25 | 25,874,688 |
| NXTC | NextCure Inc | 2019-05-13 | 1,103,570 | 0.82 | 904,927 |
Holding Weightings of Stella Xu
Stella Xu Form 4 Trading Tracker
According to the SEC Form 4 filings, Stella Xu has made a total of 2 transactions in Design Therapeutics Inc (DSGN) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Design Therapeutics Inc is the sale of 590,880 shares on March 22, 2022, which brought Stella Xu around $11 Million.
According to the SEC Form 4 filings, Stella Xu has made a total of 0 transactions in NextCure Inc (NXTC) over the past 5 years. The most-recent trade in NextCure Inc is the acquisition of 125,000 shares on May 13, 2019, which cost Stella Xu around $2 Million.
Insider Trading History of Stella Xu
- 1
Stella Xu Trading Performance
GuruFocus tracks the stock performance after each of Stella Xu's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stella Xu is 2.53%. GuruFocus also compares Stella Xu's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stella Xu within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stella Xu's insider trading performs compared to the benchmark.
Performance of Stella Xu
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -15.44 | | | | | |
| Relative Return to S&P 500(%) | -19.67 | | | | | |
Stella Xu Ownership Network
Stella Xu Owned Company Details
What does Tempest Therapeutics Inc do?
Who are the key executives at Tempest Therapeutics Inc?
Stella Xu is the director of Tempest Therapeutics Inc. Other key executives at Tempest Therapeutics Inc include 10 percent owner Versant Venture Capital Vi, L.p. , director & Chief Executive Officer Stephen R Brady , and Chief Medical Officer Samuel Whiting .
Tempest Therapeutics Inc (TPST) Insider Trades Summary
Over the past 18 months, Stella Xu made no insider transaction in Tempest Therapeutics Inc (TPST). Other recent insider transactions involving Tempest Therapeutics Inc (TPST) include a net sale of 787,999 shares made by Versant Venture Capital Vi, L.p. , a net purchase of 35,000 shares made by Stephen R Brady , and a net purchase of 4,672 shares made by Samuel Whiting .
In summary, during the past 3 months, insiders sold 0 shares of Tempest Therapeutics Inc (TPST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 787,999 shares of Tempest Therapeutics Inc (TPST) were sold and 39,672 shares were bought by its insiders, resulting in a net sale of 748,327 shares.
Tempest Therapeutics Inc (TPST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tempest Therapeutics Inc Insider Transactions
Stella Xu Mailing Address
Above is the net worth, insider trading, and ownership report for Stella Xu. You might contact Stella Xu via mailing address: C/o Armo Biosciences, Inc., 575 Chesapeake Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
